JP Morgan Chase’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,077,089
| Closed | -$4.31M | – | 5955 |
|
|
2019
Q4 | $4.31M | Sell |
1,077,089
-1,129,185
| -51% | -$5.3M | ﹤0.01% | 2801 |
|
|
2019
Q3 | $10.8M | Buy |
2,206,274
+760,440
| +53% | +$4.26M | ﹤0.01% | 2084 |
|
|
2019
Q2 | $8.63M | Buy |
1,445,834
+1,150,740
| +390% | +$6.12M | ﹤0.01% | 2215 |
|
|
2019
Q1 | $1.72M | Buy |
295,094
+221,009
| +298% | +$2.28M | ﹤0.01% | 3437 |
|
|
2018
Q4 | $997K | Sell |
74,085
-138,584
| -65% | -$2.34M | ﹤0.01% | 3752 |
|
|
2018
Q3 | $4.13M | Sell |
212,669
-304,567
| -59% | -$6.48M | ﹤0.01% | 2896 |
|
|
2018
Q2 | $13.2M | Sell |
517,236
-437,420
| -46% | -$10.2M | ﹤0.01% | 1924 |
|
|
2018
Q1 | $19.2M | Sell |
954,656
-66,113
| -6% | -$1.54M | ﹤0.01% | 1541 |
|
|
2017
Q4 | $20.5M | Buy |
1,020,769
+456,649
| +81% | +$8.98M | ﹤0.01% | 1548 |
|
|
2017
Q3 | $11.6M | Buy |
564,120
+281,498
| +100% | +$4.76M | ﹤0.01% | 1877 |
|
|
2017
Q2 | $4.18M | Buy |
282,622
+275,387
| +3,806% | +$4.59M | ﹤0.01% | 2595 |
|
|
2017
Q1 | $116K | Buy |
7,235
+3,056
| +73% | +$44.1K | ﹤0.01% | 4266 |
|
|
2016
Q4 | $52K | Sell |
4,179
-617
| -13% | -$11.5K | ﹤0.01% | 4542 |
|
|
2016
Q3 | $134K | Sell |
4,796
-270,851
| -98% | -$9.09M | ﹤0.01% | 3796 |
|
|
2016
Q2 | $9.65M | Sell |
275,647
-5,988
| -2% | -$188K | ﹤0.01% | 1860 |
|
|
2016
Q1 | $7.72M | Buy |
281,635
+49,630
| +21% | +$1.46M | ﹤0.01% | 1939 |
|
|
2015
Q4 | $7.94M | Buy |
232,005
+79,838
| +52% | +$2.49M | ﹤0.01% | 1949 |
|
|
2015
Q3 | $4.37M | Buy |
+152,167
| New | +$6.51M | ﹤0.01% | 2305 |
|
|
2015
Q2 | – | Sell |
-15,442
| Closed | -$534K | – | 4273 |
|
|
2015
Q1 | $534K | Sell |
15,442
-607
| -4% | -$16.5K | ﹤0.01% | 3509 |
|
|
2014
Q4 | $439K | Buy |
+16,049
| New | +$389K | ﹤0.01% | 3725 |
|
Other funds holding DPLO
JP Morgan Chase's DPLO Position: Q1 2020 in Review
JP Morgan Chase sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 1,077,089 shares — an estimated $4.31M sold.
JP Morgan Chase first reported a position in DPLO in Q4 2014 and held it in 20 quarters. The position peaked at $20.5M in Q4 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- JP Morgan Chase reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- JP Morgan Chase sold 1,077,089 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $4.31M.
- JP Morgan Chase first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 20 quarters.
- JP Morgan Chase's DIPLOMAT PHARMACY, INC. position peaked at $20.5M in Q4 2017.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.